New hope for head and neck cancer: drug plus radiation shows promise in early trial
NCT ID NCT05245682
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This early-phase study tests whether combining the drug tolinapant with radiation therapy is safe and doable for people with head and neck cancer that hasn't been treated yet and has spread locally. Participants are those who can't take the standard chemo drug cisplatin. The goal is to see if this combo can kill more cancer cells without causing too many side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.